OptiNose, Inc. Common Stock

Go to OptiNose, Inc. Common Stock Website

$9.60

(%)
Live
Previous Close

$9.6

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Paratek Pharmaceuticals has completed the acquisition of Optinose, expanding its portfolio of specialty therapies. The transaction was financed with capital from Paratek, B-FLEXION Life Sciences, and Novo Holdings, as well as debt financing from Oaktree Capital Management.

Related tickers: OPTN.

Read Full Article

Monteverde & Associates PC is investigating the proposed mergers of OptiNose, Acelyrin, Akoya Biosciences, and Shyft Group. The firm is urging shareholders to take action regarding these mergers.

Related tickers: OPTN, SLRN, AKYA, SHYF.

Read Full Article
Trending Tickers

Please sign in to view